Consumers can now use ChatGPT to efficiently shop Kin’s digital home insurance experience

CHICAGO, Oct. 23, 2026 /PRNewswire/ — Building on its recent announcement that AI shopping agents like Meta’s Muse are welcome to shop on Kin.com, Kin is making its digital home insurance experience even easier for AI to shop. Kin, the direct-to-consumer provider of insurance and home finance solutions for homeowners, today announced that it has enabled WebMCP in its digital quoting experience. The new capability gives ChatGPT a faster and more efficient way to interact with Kin.com on a consumer’s behalf.

Homeowners can go from their AI agent prompt to a customized Kin home insurance quote ready for purchase in minutes due to the data-informed Kin.com quoting process.

“We said that Kin will win the AI shopping experience, and we meant it,” said Kin Founder and CEO Sean Harper. “People are going to increasingly ask AI to do the tedious work of shopping for them. We want someone to be able to tell ChatGPT, ‘Help me shop for home insurance,’ and make it incredibly easy for that AI agent to shop Kin.”

Unlike plug-ins that require installation, WebMCP is an open web standard which lets AI agents work directly with Kin.com, creating a more efficient way to interact with Kin’s digital experience, and making it easier for them to help consumers shop for home insurance. For consumers, that means AI can do more of the repetitive work involved in insurance shopping, while Kin makes its experience easier for those AI agents to navigate. 

Built for the Way Consumers Will Shop

The launch builds on Kin’s announcement that it would welcome Meta’s Muse and other AI shopping agents to Kin.com rather than block them. In Kin’s testing, Muse was able to retrieve home insurance quotes after asking consumers only a handful of questions. Likewise, with ChatGPT, Kin testing found consumers could easily price out home insurance in a clear side-by-side view with minimal questions. The technology improves daily, and Kin is committed to implementing open standards like WebMCP, which ChatGPT supports for paid users on its browser-based platform. While free ChatGPT accounts cannot use this protocol, consumers can still easily get a quote at kin.com.

Kin was built to sell home insurance directly to consumers through a digital experience, without relying on external agents. It also analyzes thousands of data points about individual homes, meaning much of the information needed to generate a quote can already be gathered without asking the homeowner.

“We didn’t have to reinvent Kin for AI shopping,” Harper said. “We already built a direct digital experience, we already have the data to answer most of the questions about a home, and we don’t depend on someone in the middle to sell the product. AI shopping rewards a lot of the things we’ve been building for years.”

A New Way to Shop for Insurance

Kin expects AI agents to become increasingly capable of helping consumers gather information, understand coverage and shop across insurance providers. As those capabilities improve, Kin plans to continue making its digital experience easier for both people and the AI agents working on their behalf.

“Five years from now, opening a bunch of browser tabs and filling out the same information over and over is going to seem pretty antiquated,” Harper said. “You’ll tell your AI what you need and it will go do the work. We’ve built Kin to win in that world.”

About Kin
Kin helps homeowners save money, simplify tasks, and protect their most valuable assets. By offering direct-to-consumer digital home and auto insurance alongside home finance services, the company focuses on supporting underserved homeowners in states with high catastrophic risk. Kin provides more convenient and affordable home and auto insurance coverage by eliminating the need for external agents and analyzing thousands of data points to provide transparent, accurate pricing. Kin’s AI-native technology platform delivers a seamless customer experience, customized options, and fast, high-quality service. To learn more, visit www.kin.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/kin-becomes-first-us-home-insurer-to-enable-webmcp-for-ai-shopping-302917809.html

SOURCE Kin Insurance, Inc.

Built on the OPUS Lakehouse, the new capability gives life sciences and healthcare customers SQL-based access to serialized event data, with integrated reporting and analytics through OPUS Reports and Dashboards

BOSTON, Oct. 23, 2026 /PRNewswire/ — TraceLink, the world’s largest Agentic Business Network, today announced the launch of Track & Trace Lakehouse, a new capability that gives life sciences and healthcare companies analytical access to end-to-end serialized product events. Built on the OPUS Lakehouse—TraceLink’s metadata-driven analytical foundation for high-volume supply chain events—the new capability makes this information available for advanced analytics, reporting, and governed Agentic Business Processes, helping companies reduce compliance risk, accelerate exception resolution, improve inventory management, and strengthen business performance.

“For years, the industry has measured the value of Track & Trace largely through regulatory compliance. That is only a fraction of what this information can deliver,” said Shabbir Dahod, President and CEO of TraceLink. “The intelligence embedded in Track & Trace events can fundamentally change how pharmaceutical companies make decisions, coordinate operations, and drive business performance. With Track & Trace Lakehouse, we are making these insights accessible at enterprise scale and enabling companies to put them to work throughout their supply networks.”

Bringing Track & Trace Intelligence Into the OPUS Platform

Life sciences companies generate vast volumes of Track & Trace data to meet global regulatory requirements, yet accessing and analyzing this information across systems remains a challenge, limiting its use for exception investigation, transaction reconciliation, and inventory management.

Using Data Mesh pipelines, Track & Trace Lakehouse streams product movement, compliance, and information-exchange events into the OPUS Lakehouse as they occur, making the data available for analysis within an hour of the underlying transaction. Customers gain SQL-based access to EPCIS and related event data from TraceLink’s Serial Number Exchange, Serialized Operations Manager, Product Information Exchange, and EU Compliance.

Through native integration with OPUS Reports and Dashboards (ORD), customers can run complex queries, create reports and visualizations, and schedule recurring analysis. Teams can also reconcile serialized events with ERP and business transaction data to identify discrepancies, reduce manual investigation, and accelerate resolution.

Beyond compliance, companies can use product-level event histories to improve returns reconciliation and revenue recovery, identify issues that could delay market availability, and manage inventory approaching expiration to reduce losses and optimize working capital.

Using Track & Trace Data to Power Agentic Business Processes

Track & Trace Lakehouse also provides a foundation for incorporating serialized product movement, compliance, and information-exchange events into the operational context available to OPUS Agents and OPUS Actions within governed Agentic Business Processes.

With access to product-level event histories, OPUS Agents can help identify conditions requiring attention, evaluate discrepancies, and support decisions about corrective action. OPUS Actions can then initiate governed follow-up work across business processes, systems, and human teams within defined rules, permissions, and approval requirements.

This extends the value of Track & Trace information beyond retrospective reporting, enabling companies to use serialized event data to inform more timely, coordinated operational decisions.

TraceLink showcased Track & Trace Lakehouse at FutureLink Barcelona, demonstrating how supply chain data can drive greater visibility and operational intelligence.

About TraceLink

TraceLink powers the transformation to an Agentic Supply Chain Operating Model, enabling organizations to perform and improve supply chain work across their business and trading partner networks. The OPUS Agentic Supply Chain Operating System brings together Agentic Business Processes, Agentic Control Towers, governed OPUS Agents, and the Integrate-Once™ Agentic Business Network to link systems, end-to-end business transactions, and collaborative peer-to-peer processes with trusted, real-time operational context. In this agentic environment, humans and agents work together with greater speed, reasoning, control, and accountability to improve organizational productivity, service, inventory, working capital, cost, compliance, quality, resilience, and revenue performance.

Learn more at www.tracelink.com.

SOURCE TraceLink, Inc.

DELRAY BEACH, Fla., Oct. 23, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Next-generation Sequencing Services Market is projected to reach USD 9.37 billion by 2031 from USD 3.96 billion in 2026, at a CAGR of 18.8% during the forecast period.

Browse 593 market data Tables and 55 Figures spread through 436 Pages and in-depth TOC on “NGS Services Market- Global Forecast to 2031”

Next-generation Sequencing Services Market Size & Forecast:

Market Size Available for Years: 2026–20312026 Market Size: USD 3.96 billion2031 Projected Market Size: USD 9.37 billionCAGR (2026–2031): 18.8%

Next-generation Sequencing Services Market Trends & Insights:

North America accounted for the largest share of 40.9% of the NGS services market in 2025.By type, sequencing services accounted for the largest share of 75.6% of the NGS services market in 2025.By workflow, sequencing accounted for the largest share, at 84.5%, of the NGS services market in 2025.By application, diagnostic applications accounted for the largest share, at 47.7%, of the NGS services market in 2025.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194102241

The NGS services market is expanding as pharmaceutical and biotechnology companies, hospitals and clinical laboratories, and academic research institutes increasingly outsource sequencing workflows to support drug discovery, clinical research, precision medicine, population genomics, and biomarker development. NGS services are widely used for whole-genome sequencing, exome and targeted sequencing, RNA sequencing, de novo sequencing, ChIP sequencing, and methyl sequencing. Growing demand for high-throughput genomic analysis is also increasing the use of presequencing services and downstream bioinformatics support. The rising adoption of long-read sequencing services and customized NGS workflows is further widening the market opportunity. In addition, increasing requirements for data analysis, visualization, interpretation, and storage are strengthening demand for integrated service offerings. These capabilities help customers access advanced sequencing technologies without substantial capital investment, improve workflow scalability, and support complex research and clinical applications.

By type, the sequencing services segment held the largest share of the NGS services market in 2025.

By type, the NGS services market is segmented into presequencing services, sequencing services, bioinformatics & data analysis services, and NGS platform services. In 2025, sequencing services accounted for the largest market share. This is primarily due to the broad use of whole-genome sequencing, exome and targeted resequencing, RNA sequencing, de novo sequencing, ChIP sequencing, and methyl sequencing across clinical research and life science applications. Pharmaceutical and biotechnology companies increasingly outsource sequencing to access advanced platforms without making large capital investments. Hospitals and clinical laboratories also use these services for cancer diagnostics, infectious disease testing, and reproductive health applications. The need for specialized expertise, high-throughput capabilities, and reliable quality control further supports demand. Growing population genomics programs and wider use of NGS in drug discovery are also strengthening sequencing services’ position in the market.

By workflow, the sequencing segment held the largest share of the NGS services market in 2025.

By workflow, the NGS services market is segmented into pre-sequencing, sequencing, and data analysis. In 2025, sequencing accounted for the largest market share. This is mainly due to the extensive use of sequencing workflows across whole-genome sequencing, exome and targeted sequencing, RNA sequencing, de novo sequencing, ChIP sequencing, and methyl sequencing. Sequencing represents the core revenue-generating stage of NGS service delivery and requires access to advanced platforms, skilled personnel, and high-throughput laboratory infrastructure. Pharmaceutical and biotechnology companies increasingly outsource this stage to support biomarker discovery, drug development, and translational research. Hospitals and clinical laboratories also rely on sequencing workflows for cancer, infectious disease, and reproductive health applications. Growing population genomics programs and rising demand for customized NGS studies further support the sequencing workflow segment’s leading position.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=194102241

By region, North America accounted for the largest share of the market in 2025.

In 2025, North America held the largest share of the NGS services market. This is supported by strong genomics research infrastructure, high adoption of outsourced sequencing workflows, substantial investment in precision medicine and drug development, and the presence of leading pharmaceutical and biotechnology companies, hospitals, clinical laboratories, and research institutes. The region also benefits from large-scale population genomics programs and increasing use of NGS in cancer diagnostics, infectious disease testing, and reproductive health applications. Growing demand for whole-genome sequencing, RNA sequencing, targeted sequencing, and advanced bioinformatics services continues to support market growth. Wider adoption of long-read sequencing and customized NGS services is further strengthening North America’s position in the global market.

Key Players

Leading players in the Next-generation Sequencing Services companies include Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Eurofins Scientific (Luxembourg), Azenta US Inc. (US), BGI Group (China), Revvity (US), Agilent Technologies, Inc. (US), PacBio (US), Oxford Nanopore Technologies plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), and LGC Limited (UK), among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=194102241

Next-generation Sequencing Services Market – Investment & funding +Merger & Acquisition

Investment and Funding Context

The NGS services market is witnessing increasing investment, driven by rising demand for genomic diagnostics, research sequencing, precision medicine, and integrated bioinformatics services. Funding activity is increasingly focused on expanding sequencing capacity, strengthening clinical genomics capabilities, broadening geographic reach, and supporting end-to-end genomic analysis. Service providers are also investing in advanced sequencing workflows and data interpretation to address growing research and clinical requirements. For instance, in July 2025, MedGenome raised USD 47.5 million in Series E funding, co-led by Maj Invest and Novo Holdings. The funding is intended to expand access to MedGenome’s genomics and integrated diagnostics offerings across India and other emerging markets. The investment highlights the growing strategic value of scalable sequencing, genomic diagnostics, and research services within the NGS services market.

Revenue Shift Context

The NGS services market is gradually shifting revenue from standardized sequencing offerings to higher-value services such as long-read sequencing, single-cell and spatial sequencing, customized NGS workflows, and integrated bioinformatics & data analysis. The global NGS services market is projected to increase from USD 3.96 billion in 2026 to USD 9.37 billion by 2031, at a CAGR of 18.8%, with a growing share of revenue expected from advanced sequencing and data-intensive services. Conventional offerings such as whole-genome sequencing, whole-exome sequencing, RNA sequencing, and targeted sequencing remain an important revenue base. However, clinical-grade genomic testing, multi-omics analysis, population genomics programs, and advanced data interpretation services are gaining adoption across academic research, pharmaceutical and biotechnology, and clinical settings.

Mergers and Acquisitions

Mergers and acquisitions in the NGS services market are being driven by the need to broaden sequencing portfolios, strengthen bioinformatics and data interpretation capabilities, expand clinical genomics services, and increase access to advanced areas such as long-read sequencing, single-cell analysis, population genomics, and precision medicine workflows.

NGS SERVICES MARKET: MERGERS AND ACQUISITIONS, JANUARY 2023–AUGUST 2026

Company Revenue Share Details

The top five players collectively account for approximately 36–41% of the global NGS services market, indicating a competitive landscape. This reflects the presence of numerous specialized sequencing, genomics, clinical testing, and bioinformatics service providers alongside large global life sciences companies. Key market participants include Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Eurofins Scientific (Luxembourg), Azenta US, Inc. (US), BGI Group (China), Revvity (US), Agilent Technologies, Inc. (US), PacBio (US), Oxford Nanopore Technologies plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), and LGC Limited (UK). These companies compete through broad sequencing capabilities, specialized NGS workflows, geographic reach, laboratory infrastructure, bioinformatics expertise, and support for research and clinical applications. Continued expansion into long-read sequencing, customized NGS services, clinical genomics, and integrated data analysis is further shaping competition in the market.

Browse Adjacent Market: Biotechnology Market Research Reports &Consulting

See More Latest Biotechnology Reports:

Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition – Global Forecast to 2031

Bioinformatics Market by Offerings (Software (Genomics, Multiomics, Proteomics), Services (Analysis, Sequencing)), Function (Variant & Structural Analysis), Use Case (Drug Discovery, Biomarker), End User (Pharma & Biotech, CROs) – Global Forecast to 2031

About MarketsandMarkets™  

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/next-generation-sequencing-services-companies.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/ngs-services.asp

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/next-generation-sequencing-services-market-worth-9-37-billion-by-2031—exclusive-report-by-marketsandmarkets-302917996.html